Study period | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Screening | Treatment | Follow-up | ||||||||||||
Week | 0 | 1 | 2 | 3 | 4 | 5 | 6 | 10 | ||||||
Visit | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 |
Enrollment: | ||||||||||||||
Informed consent | X | |||||||||||||
Demographic characteristics | X | |||||||||||||
Medical history | X | |||||||||||||
Vital signs | X | X | X | X | X | X | X | X | X | X | X | X | X | X |
Physical examination | X | X | ||||||||||||
Urinalysis | X | X | ||||||||||||
Inclusion/Exclusion criteria | X | |||||||||||||
Random allocation | X | |||||||||||||
Intervention: | ||||||||||||||
Acupuncture treatment | X | X | X | X | X | X | X | X | X | X | X | X | ||
Assessments: | ||||||||||||||
3-day bladder diary | X | X | X | |||||||||||
OABSS | X | X | X | |||||||||||
KHQ | X | X | X | |||||||||||
Adverse events | X | X | X | X | X | X | X | X | X | X | X | X | X |